Carcinoid syndrome classification
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Anum Gull M.B.B.S.[2]Parminder Dhingra, M.D. [3]
Overview
Classification
- Gastroenteropancreatic neuroendocrine tumors(GET-NETs) are located in different parts of GI tract.
- GET-NETs produce a number of secretory products, resulting in a wide range of clinical symptoms.
- Gastroenteropancreatic neuroendocrine tumors(GET-NETs) can be classified according to their location in GIT tract. [1] [2][3]
Carcinoid syndrome Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Carcinoid syndrome classification On the Web |
American Roentgen Ray Society Images of Carcinoid syndrome classification |
Risk calculators and risk factors for Carcinoid syndrome classification |
Foregut | Midgut | Hindgut | |
---|---|---|---|
Location |
|
|
|
Hormones produced |
|
|
Variable |
Possibility of carcinoid syndrome | Rare, and atypical when it happens | Classic | Rare |
References
- ↑ Büyükaşık K, Arı A, Tatar C, Akçe B, Sevinç MM, Sarı S, Paşaoğlu E, Bektaş H (2017). "Clinicopathological features of gastroenteropancreatic neuroendocrine tumors: A retrospective evaluation of 42 cases". Turk J Surg. 33 (4): 279–283. doi:10.5152/UCD.2017.3685. PMID 29260133.
- ↑ Davies L, Weickert MO (2016). "Gastroenteropancreatic neuroendocrine tumours: an overview". Br J Nurs. 25 (4): S12–5. doi:10.12968/bjon.2016.25.4.S12. PMID 26911175.
- ↑ Oberg K, Castellano D (March 2011). "Current knowledge on diagnosis and staging of neuroendocrine tumors". Cancer Metastasis Rev. 30 Suppl 1: 3–7. doi:10.1007/s10555-011-9292-1. PMID 21311954.